Autor: |
Yihan Wang, Zhong Zuo, Yuxi Zhu, Hong-Tao Tie |
Rok vydání: |
2021 |
Předmět: |
|
Zdroj: |
SN Comprehensive Clinical Medicine. 3:343-345 |
ISSN: |
2523-8973 |
Popis: |
Updated data referring to efficacy and safety of crizotinib therapy have been presented. We reported a rare case of the 71-year-old elder heavy smoker with ALK-rearranged advanced lung adenocarcinoma. Within 7 months of crizotinib treatment, the giant lung tumor disappeared, and a complete response was achieved. The case illustrates exemplarily that crizotinib is effective and manageable as a first-line treatment in advanced NSCLC with ALK rearrangement. It also implies that the elder heavy smoker with such rare “god-given” ALK rearrangement might benefit more from ALK inhibitor. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|